Leadership Overview
FTI has 5 executives leading key functions including strategy, operations, technology development, and organizational growth.
Focused on delivering mission-tailored solutions to the federal government, FTI drives critical decision-making capabilities through advanced technology and research-backed services across the United States.
Focused on delivering mission-tailored solutions to the federal government, FTI drives critical decision-making capabilities through advanced technology and research-backed services across the United States.
Leadership Roles at FTI
Juohao Li - Chief Executive Officer
Juohao Li, the Chief Executive Officer at FTI, directs the overarching strategic vision for the organization. Focusing on the delivery of technology-enabled solutions for the Department of Defense, the Chief Executive Officer manages high-level partnerships across the federal landscape. This leadership role involves aligning internal research and development initiatives with the evolving requirements of the Intelligence Community. By optimizing operational efficiency across 39 states, Juohao Li ensures the company maintains a competitive edge in the defense sector. The Chief Executive Officer also coordinates with the board to secure long-term growth objectives. Through rigorous oversight of corporate governance, the Chief Executive Officer maintains the integrity of mission-critical projects. Ultimately, Li secures the financial health of the enterprise while fostering a culture of innovation that supports complex government missions.
Jose Hidalgo - President & Chief Executive Officer
Jose Hidalgo, the President & Chief Executive Officer at FTI, executes the daily operational mandates required to support federal clients. Overseeing the integration of mission-tailored solutions, the President & Chief Executive Officer drives the expansion of service capabilities within the Intelligence Community. This leadership role involves managing the complex logistics of facilities across the United States and Puerto Rico. By streamlining internal processes, the President & Chief Executive Officer ensures that all technology-enabled projects meet stringent government standards. Jose Hidalgo also facilitates cross-departmental collaboration to enhance decision-support tools for defense personnel. Through the implementation of scalable business models, the President & Chief Executive Officer strengthens the market position of the firm. Ultimately, Hidalgo maintains the operational readiness necessary to address the most pressing challenges facing the federal government today.
Gary Marcus - President
Gary Marcus, the President at FTI, manages the execution of business development strategies across the federal sector. Overseeing the client engagement teams, the President ensures that the company effectively communicates the value of its technology-enabled solutions to the Department of Defense. This leadership role involves identifying new market opportunities and expanding the firm's presence in key geographic regions. By aligning sales objectives with the company's core mission, the President supports the growth of the enterprise. Gary Marcus also coordinates with the technical leadership to ensure that service delivery meets the high expectations of government partners. Through the cultivation of strong relationships with stakeholders, the President maintains the firm's competitive advantage. Ultimately, Marcus drives the commercial success of the organization by ensuring that every project delivers measurable value to the federal government and its diverse mission requirements.
Michael Ehrlich - Executive Vice President & Chief Technology Officer
Michael Ehrlich, the Executive Vice President & Chief Technology Officer at FTI, architects the technical roadmap for all research and development initiatives. Overseeing the engineering teams, the Executive Vice President & Chief Technology Officer ensures that every solution aligns with the specific mission requirements of the Department of Defense. This leadership role involves evaluating emerging technologies to maintain the firm's status as a leader in defense innovation. By managing the technical infrastructure across multiple secure facilities, the Executive Vice President & Chief Technology Officer guarantees the reliability of data-driven decision tools. Michael Ehrlich also collaborates with other C-suite leaders to integrate new software capabilities into existing government frameworks. Through the continuous refinement of technical standards, the Executive Vice President & Chief Technology Officer supports the long-term success of federal missions. Ultimately, Ehrlich drives the technological evolution of the entire organization.
Besufkad Menji - Co-Founder & Chief Technology Officer
Besufkad Menji, the Co-Founder & Chief Technology Officer at FTI, directs the foundational research efforts that underpin the company's service offerings. Focusing on the development of proprietary algorithms and analytical platforms, the Co-Founder & Chief Technology Officer ensures that the firm provides superior decision-support capabilities to the Intelligence Community. This leadership role involves mentoring technical staff and fostering a culture of scientific inquiry. By overseeing the implementation of advanced computing solutions, the Co-Founder & Chief Technology Officer enhances the operational impact of the company across its national footprint. Besufkad Menji also works closely with the executive team to translate complex technical requirements into actionable government solutions. Through the application of cutting-edge research, the Co-Founder & Chief Technology Officer secures the firm's reputation for excellence. Ultimately, Menji drives the innovation cycle that keeps the company at the forefront of the defense industry.
Explore Leadership Teams in Business Services
Genentech, based in South San Francisco, California, is a biotechnology company specializing in the development of innovative therapies for serious medical conditions. Founded in 1976, Genentech serves the healthcare sector with a focus on research and development of biopharmaceuticals to improve patient outcomes.
Company Leadership AM
LL
Novavax, Inc. is a biotechnology company incorporated in 1987 and headquartered in Gaithersburg, Maryland, focused on discovering, developing, and commercializing vaccines to protect against serious infectious diseases. The company's proprietary technology platform combines a recombinant protein approach, nanoparticle technology, and a patented adjuvant to enhance immune response. Novavax's pipeline spans vaccine candidates targeting infectious diseases including COVID-19, influenza, respiratory syncytial virus, malaria, shingles, and other pathogens, with ongoing exploration of its adjuvant platform in oncology. The company maintains a strategic partnership with Sanofi for COVID-19 vaccine commercialization and has established licensing and collaboration agreements with major global pharmaceutical companies. Novavax trades on the NASDAQ under the ticker symbol NVAX.
Company Leadership JJ

LF
Founded in 1945 and headquartered in Pretoria, South Africa, CSIR is a scientific and technology research, development and implementation organization.
Company Leadership KS
LS
EO
JC
Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster.
Company Leadership GS
AR
